Tenet Healthcare Corporat...

NYSE: THC · Real-Time Price · USD
172.03
-0.33 (-0.19%)
At close: Aug 15, 2025, 3:59 PM
171.99
-0.02%
After-hours: Aug 15, 2025, 04:10 PM EDT

Tenet Healthcare Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
20.69B 20.52B 20.66B 20.97B 20.92B 20.89B 20.55B 20.16B 19.89B 19.45B 19.17B 19.04B 19.13B 19.45B 19.48B 19.54B 19.21B 17.9B
Cost of Revenue
10.8B 10.81B 13.3B 17.03B 14.58B 11.04B 7.32B 3.52B 3.46B 3.38B 3.27B 3.25B 3.26B 3.31B 3.33B 3.31B 3.27B 3.02B
Gross Profit
9.89B 9.71B 7.36B 3.94B 6.34B 9.86B 13.23B 16.64B 16.43B 16.07B 15.9B 15.79B 15.87B 16.14B 16.16B 16.23B 15.94B 14.88B
Operating Income
3.71B 3.52B 3.34B 3.24B 2.72B 2.65B 2.5B 2.31B 2.34B 2.29B 2.33B 2.55B 2.97B 3B 2.87B 3.04B 2.3B 2.18B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
2.98B 2.93B 5.25B 5.11B 4.54B 4.32B 1.62B 1.42B 1.45B 1.35B 1.34B 1.55B 1.95B 2B 1.89B 2.04B 958M 853M
Net Income
1.48B 1.46B 3.2B 3.13B 2.75B 2.62B 764M 794M 961M 1.02B 1B 975M 1.16B 1.1B 914M 1.08B 434M 403M
Selling & General & Admin
8.59B 8.6B 8.8B 9.02B 9.09B 9.21B 9.15B 9.14B 9.08B 8.92B 8.84B 8.73B 8.71B 8.86B 8.88B 8.91B 8.85B 8.43B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
-2.4B -216M 2.06B 847M 2.37B 2.34B 1.33B 2.52B 3.69B 4.81B 4.64B 3.44B 2.27B 1.14B 14M 14M 1.35B 1.35B
Operating Expenses
6.19B 9.71B 11.23B 11.63B 14.54B 14.63B 14.52B 14.3B 14.09B 13.73B 13.49B 13.26B 13.32B 13.6B 13.75B 13.56B 13.57B 12.58B
Interest Expense
815M 812M 826M 850M 875M 898M 901M 893M 888M 884M 890M 892M 897M 910M 923M 944M 980M 1B
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
16.98B 17B 17.33B 17.73B 18.19B 18.26B 18.11B 17.82B 17.55B 17.11B 16.76B 16.51B 16.58B 16.91B 17.08B 16.87B 16.85B 15.6B
Income Tax Expense
587M 577M 1.18B 1.16B 1B 972M 306M 290M 323M 329M 344M 405M 490M 465M 411M 433M 39M 23M
Shares Outstanding (Basic)
91.14M 94.24M 95.1M 95.67M 97.27M 99.58M 100.96M 101.54M 101.77M 102.29M 104.52M 107.92M 107.79M 107.48M 107.15M 107.05M 106.82M 106.31M
Shares Outstanding (Diluted)
91.79M 95.02M 95.88M 96.65M 98.44M 100.6M 104.17M 104.42M 104.78M 106.01M 106.37M 109.89M 108.75M 112.02M 108.89M 108.76M 108.57M 108.06M
EPS (Basic)
15.75 15.25 32.54 31.62 27.67 26.22 7.51 7.71 9.20 9.65 9.36 9.06 10.77 10.22 8.53 10.13 4.08 3.81
EPS (Diluted)
15.62 15.12 32.23 31.25 27.33 25.86 7.27 7.51 8.98 9.46 9.16 8.87 10.56 10.01 8.42 9.99 4.00 3.73
EBITDA
4.62B 4.44B 4.3B 4.3B 3.77B 3.67B 3.61B 3.54B 3.43B 3.33B 3.21B 3.11B 3.23B 3.29B 3.24B 3.24B 2.61B 2.04B
EBIT
3.8B 3.63B 3.48B 3.46B 2.9B 2.8B 2.73B 2.66B 2.58B 2.48B 2.37B 2.28B 2.4B 2.46B 2.39B 2.35B 2.11B 1.55B
Depreciation & Amortization
816M 816M 818M 841M 856M 861M 870M 867M 852M 855M 841M 829M 829M 834M 855M 887M 893M 878M